GNPX Genprex, Inc: Bozor kapitallashuvining balans qiymatiga nisbati

Genprex, Inc (GNPX) - korporativ logo

Genprex, Inc. (GNPX) raqobatchilar uchun kirishning sezilarli to'siqlarini yaratuvchi eksklyuziv patentlarga tayanadi, garchi bozorga chiqish yo'li FDA ning qat'iy tekshiruvlari tufayli murakkablashgan bo'lsa-da. Genprex, Inc. (GNPX) diabet va o'pka o'smalari uchun gen terapiyalarini ishlab chiqish bo'yicha ekspert sifatida tan olingan. GURU.Markets platformasidagi qimmatli qog'ozlarning ushbu narx trayektoriyasi 0.07 darajasida qayd etilgan. Tadqiqot samaradorligi aniq sintez va sekvenslash uchun avtonom robotlarning joriy etilishi hisobiga oshirilmoqda.

Genprex, Inc. (GNPX) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 28.10.2026gacha

GNPX (Genprex Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Genprex, Inc.|GNPX - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Genprex, Inc|GNPX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Genprex|GNPX - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati genprex.com|GNPX - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Genprex, Inc.|GNPX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Genprex, Inc|GNPX - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Genprex, Inc
Fundamental baholash:GNPX (Genprex, Inc.)
Genprex Inc. tayyor mahsulotlari

Genprex, Inc. gen terapiyasini ishlab chiqish jarayoni FDA ning qat'iy nazorati va klinik sinovlarning yuqori xarajatlariga bog'liqdir. Ushbu ko'rsatkich joriy bozor aksiyalar narxini emitentning sof aktivlarining balans qiymati bilan solishtiradi. Ushbu hisob-kitob biznesning moddiy aktivlar bazasiga nisbatan qanchalik hadda haddan tashqari qimmat baholanganini aniqlaydi. Investor kompaniyaning patent "himoyasi" bozor tomonidan qanchalik darajada kapitallashTrayayotganini baholaydi. Bozor qiymatining balans kapitaliga nisbatini tahlil qilish orqali fundamental baholash muvozanatining buzilishini aniqlash mumkin.

Asosiy raqobatchilar

Kapitallashuvning sof aktivlarga nisbati BeiGene Ltd|halozyme.com (HALO) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|DCTH - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati YMAB|AURA (Aura Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CADL - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati accuray.com (ARAY)|SELLAS Life Sciences (SLS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|HURA - Kapitallashuvning sof aktivlarga nisbati|Protara Therapeutics - Kapitallashuvning sof aktivlarga nisbati|FATE: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati aadibio.com WHWK|TScan Therapeutics, Inc. (TCRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CSBR (Champions Oncology Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti XBiotech USA|CVM: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati ostherapies.com (OSTX)|RADX: Bozor kapitallashuvining balans qiymatiga nisbati|Artiva Biotherapeutics Inc. - Bozor qiymatining balans qiymatiga koeffitsiyenti|Adlai Nortye Limited (ANL) - Bozor qiymatining balans qiymatiga nisbati|VERU: Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Tempest Therapeutics (TPST)|XLO (Xilio Therapeutics) - Sof aktivlarga nisbatan bozor kapitallashuvi|RENB - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Mural Bio|Kairos Pharma Ltd - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti onkuretherapeutics.com OKUR|GDTC - Kapitallashuvning sof aktivlarga nisbati|CRIS - Kapitallashuvning balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Apollomics Corp (APLM)|THAR - Balans qiymatiga nisbatan bozor qiymati|advanbiomed.com - Bozor kapitallashuvining balans qiymatiga nisbati|CLDI (Calidi Biotherapeutics, Inc.) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Sunshine Biopharma (SBFM)|Kapitallashuvning balans qiymatiga nisbati Xenetic Bio|Bozor kapitallashuvining balans qiymatiga nisbati SLRX (Salarius Pharmaceuticals, Inc.)|Kapitallashuvning sof aktivlarga nisbati Purple Biotech Ltd PPBT|Kapitallashuvning sof aktivlarga nisbati AONC|Balans qiymatiga nisbatan bozor kapitallashuvi BeiGene Ltd BGNE|Bozor kapitallashuvining balans qiymatiga nisbati CKPT|ELEV: Bozor qiymatining xususiy kapitalga nisbati|Bozor qiymatining balans qiymatiga nisbati icadmed.com|IKNA (Ikena Oncology) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Notable Labs Inc. NTBL|Sof aktivlarga nisbatan bozor kapitallashuvi Viracta (VIRX)|Kapitallashuvning sof aktivlarga nisbati MorphoSys AG MOR|Kapitallashuvning balans qiymatiga nisbati nayabiosciences.com (NAYA)|Ascentage Pharma - Bozor kapitallashuvining balans qiymatiga nisbati